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Gene expressionWe have developed AspAlt—a web-based comparative analytical platform for exploring the variations in
alternative transcription (AT) events and alternative splicing (AS) events in eukaryotes. AspAlt provides
integrated access to 2.1 million AT–AS annotations from 1,58,876 multi-isoform genes and has the following
user-friendly analytical features: (1) advanced graphical display to visualize and analyze AT–AS events in 46
eukaryotic genomes; (2) compare and identify the differences in AT–AS patterns among a group of genes
speciﬁed by the user or among homologous gene groups; (3) inter-database comparative viewer to analyze
the differences in the AT–AS annotations for the same gene among Ensembl, RefSeq and AceView databases;
(4) dynamically classify and generate graphical plots of AT–AS events from mRNA annotations submitted by
the user; and (5) download genomic AT–AS annotations of 46 eukaryotes in XML and tab-delimited formats.
The AspAlt resource is available at http://66.170.16.154/AspAlt.
© 2009 Elsevier Inc. All rights reserved.Introduction
Alternative transcription (AT) and alternative splicing (AS) are
ingenious mechanisms which produce variant mRNA transcripts from
eukaryotic gene templates. AT takes place during the transcription of
the gene and involves the selection of alternative transcription
initiation (ATI) and alternative transcription termination (ATT)
locations by the transcription machinery. AS occurs during the
splicing of the pre-mRNA by the spliceosome and makes use of
several processes such as the selection of alternative donor and
acceptor splice signals, skipping of exons, inclusion of cryptic exons
and retention of introns to create variant mRNA isoforms. Several
specialized databases have been developed to categorize AT–AS
events in different organisms [1–14]. The transcript diversity
produced by AT and AS (AT–AS) events plays an important role in
tissue-speciﬁc gene expression [15,16], protein diversity [17,18], gene
expression regulation [19,20], disease manifestation [21,22] and in
genome evolution [23–26].
General genome and transcriptome databases such as Ensembl
[27], RefSeq [28] and AceView [29] contain a wealth of mRNA isoform
annotations for a large number of eukaryotic organisms.While several
organisms have overlapping genomic coverage in Ensembl, RefSeqll rights reserved.and AceView, there can still be considerable variations in the mRNA
annotations for the same gene among these databases [30,31]. For
example, the human TPM3 (Tropomysin 3) gene has 14 mRNA
isoforms annotated in Ensembl, 5 in RefSeq and 28 in AceView. This
inter-database diversity in mRNA annotations poses a dilemma to
users interested in determining the actual number of isoforms and the
types of AT–AS events that occur in TPM3 or in any other gene. The
situation is further complicated by the fact that detailed annotations
of individual AT–AS events (ATI, exon skipping, intron retention,
alternative donor, etc.) are absent in Ensembl, RefSeq and AceView.
This poses a serious hurdle to users interested in comparing mRNA
isoform variations of a gene among the three databases in order to
make an informed decision about the exact distribution of AT–AS
events in the gene.
Comparative studies that analyze AT–AS variations among inter-
genomic data sets can provide useful insight on the functional and
evolutionary roles of AT–AS [32–37]. To further support such
comparative studies, the availability of a ﬂexible multi-gene compara-
tive tool that allows researchers to submit a group of genes of interest
and analyze the differences in AT–AS events among these geneswould
be extremely useful. Such an analytical tool would allow users to
perform customized comparative analysis of AT–AS variations in
tissue-speciﬁc or disease-speciﬁc gene expression datasets and also to
analyze inter-genomic AT–AS event variations among multiple
homologous genes.
49A. Bhasi et al. / Genomics 94 (2009) 48–54We have developed a web-based tool called AspAlt wherein we
have extended the basic AT–AS classiﬁcation and display metho-
dologies utilized in our previously described EuSplice project (38) to
create an advanced comparative AT–AS analytical platform. AspAlt is
well suited for inter-database comparative analysis of variations in
AT–AS annotations of a given gene across Ensembl, RefSeq and
AceView databases. It also supports customized multi-gene compara-
tive analysis of AT–AS patterns among 1,58,876 annotated eukaryotic
genes from 46 organisms and can be used for dynamic classiﬁcation
and comparative analysis of AT–AS events in user-submitted mRNA
isoform datasets. Additionally, AspAlt provides bulk downloads of
complete genomic AT–AS proﬁles of 46 organisms in both XML and
tab-delimited text formats.
Results and discussion
AspAlt is a ﬂexible platform for comparative AT–AS analysis and
provides user-friendly access to detailed annotations and graphical
visualization of 2.1 million AT–AS events (Fig. 1) from 46 eukaryotes.
Tables 1A and B gives the details of the data content in AspAlt and
reveals the variation in the AT–AS annotations among the 46
organisms and across the three source databases (Ensembl, RefSeq
and AceView).
The comparative analysis capabilities of AspAlt are described
below.
Inter-database comparative analysis of AT–AS events
In AspAlt, a signiﬁcant number of genes from 16 organisms have
overlapping AT–AS annotations among the Ensembl, RefSeq and
AceView databases (column 2 of Table 1A). This presents users with a
unique opportunity to analyze the variations in AT–AS events among
these three source databases. AspAlt's inter-database comparative
viewer, developed for this purpose, displays Ensembl-based, RefSeq-Fig. 1. The distribution of ATI, ATT, Intron Retention (IR), Alternative Acceptor (Alt.
Acceptor), Alternative Donor (Alt. Donor), Alternative Donor and Alternative Acceptor
(Alt. Donor & Acceptor), Skipped Exon and Cryptic Exon events in AspAlt.based and AceView-based graphical plots of a given gene in a single
web page. Each graphical plot depicts the distribution of AT–AS events
within the exon–intron structures of multiple mRNA isoforms of the
gene. Constitutive exons in the plots are shown in grey color while the
eight AT–AS events are displayed as follows: (1) exonswith alternative
acceptor splice sites are shown in green; (2) those with alternative
donor splice sites are shown in orange; (3) exonswith both alternative
donor and acceptor splice sites are shown in brown; (4) those with
intron retentions are shown in red; (5) exon skipping events are
representedwith a “●” symbol; (6) cryptic exons are representedwith
a “★” symbol; (7) ATI events are depicted with a “a” symbol; and (8)
ATT with a “Y” symbol. This display format allows users to efﬁciently
analyze the variations in AT–AS event annotations among source
databases. The mouse-over pop-ups that are associated with the
graphical display of exons in the plots give information about the type
of AT–AS event, the exon number, the Gene Exon Cluster to which the
exon belongs (see Materials and methods) and the position co-
ordinates of the exon within the gene and chromosome.
The capabilities of the inter-database comparative viewer can be
demonstrated with a sample query submitted to AspAlt for the human
TPM3 (Tropomysin 3) gene. The AspAlt result page for this gene
displays the Ensembl-based plot of 14 isoforms; RefSeq-based plot of 5
isoforms; and AceView-based plot of 28 isoforms (Fig. 2A). Looking at
the plots, one can see that there is a signiﬁcant variation in the AT–AS
events for TPM3 across the three source databases. The alternative
donor event occurs in Ensembl and AceView annotations of TPM3, but
is absent in its RefSeq annotations. The intron retention event and the
alternative donor and acceptor event are found in the AceView, but are
absent in Ensembl and RefSeq. Interestingly, ATI, ATT, alternative
acceptor, cryptic exon and skipped exon events are found in all three
databases.
Clicking on the “Inter-Db AT–AS Variation” button in the menu bar
above the plots displays a table with the frequency distribution of
AT–AS events of TPM3 in all three databases (Fig. 2B). The table
shows that the total number of AT–AS events for TPM3 in AceView is
quite high (134 events) compared to that in Ensembl (63 events) and
RefSeq (11 events). Users can also examine the distribution of
individual AT–AS events among the three databases and make
interesting observations, such as the frequency of skipped exon is
higher in Ensembl annotation of TPM3 than in RefSeq and AceView;
or that, intron retention is the most common AT–AS event in the
AceView annotation of TPM3.
Additional analysis of the AT–AS data of TPM3 is possible using the
following features available in AspAlt: (1) access to transcript
annotations: annotation details of each transcript isoform in its
source database can be accessed by clicking on the isoform-speciﬁc
transcript ID displayed in the plot (Fig. 2C); (2) gene details: gene
annotations can be accessed by clicking on the “Gene Info” button in
the menu bar above the plots (Fig. 2D); (3) details of AT–AS events: a
table with information on AT–AS events across transcript isoforms
of TPM3 from all three data sources can be accessed by clicking on the
“AT–AS Event Details” button in the menu bar and is useful for in-
depth analysis of the AT–AS event distributions (Fig. 2E); (4)
download options: users can download the data ﬁles of AT–AS
annotations in XML or tab-delimited formats (Fig. 2F) as well as image
ﬁles of the graphical AT–AS plots in PNG format; by clicking on the
“Download” button; and (5) zoom options: allows users to zoom in
and get a magniﬁed view of the intron–exon structure of isoforms
depicted in the plots and is useful for analyzing the AT–AS features of
small exons in large genes (Fig. 2G).
Inter-genomic comparative analysis of AT–AS events
AspAlt containsmRNA isoformannotations of 46 diverse organisms
(Tables 1A and B) making it well suited for inter-genomic comparative
analysis of AT–AS patterns. Users can submit queries for groups of
Table 1A
AspAlt data contents for 16 organisms which have overlapping mRNA annotations in E: Ensembl. R: RefSeq and A: AceView databases.
Organism (phylum; sub group) Percentage of shared
AT–AS genes
Genes with AT–AS events/total
genes (percentage of AT–AS genes)
Avg. no. of
mRNA isoformsa
Total no. of
AT–AS events
Avg. no. of
AT–AS eventsa
Homo sapiens (Chordata; mammals) E–R=23.3; R–A=12.46; E: 10982/26965 (40.73) E: 3.27 E: 71758 E: 6.53
E–A=25.31; E–R–A=7.97 R: 4121/25801 (15.97) R: 2.6 R: 12259 R: 2.97
A: 23781/58329 (40.77) A: 8.23 A: 599733 R: 25.22
Pan troglodytes (Chordata; mammals) E–R=20.2 E: 7950/24519 (32.42) E: 2.8 E: 42146 E: 5.3
R: 7381/24489 (30.14) R: 4.51 R: 63388 R: 8.59
Macaca mulatta (Chordata; mammals) E–R=0.04 E: 8074/26129 (30.9) E: 2.79 E: 57399 E: 7.11
R: 5676/23884 (23.76) R: 3.49 R: 35027 R: 6.17
Mus musculus (Chordata; mammals) E–R=9.78; R–A=5.53; E: 8353/27667 (30.19) E: 2.89 E: 44223 E: 5.29
E–A=23.88; E–R–A=2.94 R: 1969/30115 (6.54) R: 2.33 R: 6108 R: 3.1
A: 20690/37761 (54.79) A: 6.02 A: 342161 A: 16.54
Rattus norvegicus (Chordata; mammals) E–R=5.3 E: 6279/25471 (24.65) E: 2.66 E: 48146 E: 7.67
R: 1028/26501 (3.88) R: 2.64 R: 4262 R: 4.15
Monodelphis domestica (Chordata; mammals) E–R=0.01 E: 6516/20759 (31.39) E: 3.01 E: 61957 E: 9.51
R: 793/19084 (4.16) R: 2.37 R: 2251 R: 2.84
Ornithorhynchus anatinus (Chordata; mammals) E–R=0.65 E: 7561/21167 (35.72) E: 2.18 E: 41013 E: 5.42
R: 236/16367 (1.44) R: 2.24 R: 702 R: 2.97
Canis familiaris (Chordata; mammals) E–R=14.45 E: 4524/21808 (20.74) E: 2.38 E: 21920 E: 4.85
R: 4434/19770 (22.43) R: 4.13 R: 39807 R: 8.98
Equus caballus (Chordata; mammals) E–R=3.37 E: 1492/23324 (6.4) E: 2.32 E: 6975 E: 4.67
R: 557/15497 (3.59) R: 2.33 R: 1883 R: 3.38
Bos taurus (Chordata; mammals) E–R=0.69 E: 3913/22277 (17.57) E: 2.33 E: 21735 E: 5.55
R: 292/22008 (1.33) R: 2.31 R: 925 R: 3.17
Gallus gallus (Chordata; birds) E–R=2.21 E: 3901/17391 (22.43) E: 2.4 E: 20969 E: 5.38
R: 426/17966 (2.37) R: 2.34 R: 1441 R: 3.38
Danio rerio (Chordata; ﬁsh) E–R=1.47 E: 6268/25448 (24.63) E: 2.66 E: 56780 E: 9.06
R: 511/33916 (1.51) R: 2.21 R: 1549 R: 3.03
Anopheles gambiae (Arthropoda; insect) E–R=0.06 E: 473/12945 (3.65) E: 2.43 E: 1567 E: 3.31
R: 1240/13896 (8.92) R: 2.15 R: 5315 R: 4.29
Drosophila melanogaster (Arthropoda; insect) E–R=45.69 E: 3459/15090 (22.92) E: 2.93 E: 13872 E: 4.01
R: 3176/14414 (22.03) R: 2.91 R: 12210 R: 3.84
Caenorhabditis elegans (Nematoda) E–R=34.68 E: 4051/26482 (15.3) E: 2.75 E: 15439 E: 3.81
R: 2246/20444 (10.99) R: 2.43 R: 8240 R: 3.67
Arabidopsis thaliana (Plantae; land plant) R–A=28.51 R: 3799/26926 (14.11) R: 2.29 R: 10261 R: 2.7
A: 8712/27688 (31.46) A: 2.55 A: 38063 A: 4.37
a Average value calculated out of the total number of AT–AS genes.
50 A. Bhasi et al. / Genomics 94 (2009) 48–54genes from evolutionarily diverse or similar organisms and compare
AT–AS variations among them in a singleweb page. Additionally, 91.1%
of AspAlt genes have inter-genomic homolog cross-references
(Supplementary Table 1), which allows users to efﬁciently compare
the AT–AS patterns of a gene against those in its known and potential
homologs.
For example, users interested in comparing the AT–AS patterns of
the human TPM3 gene to the AT–AS patterns of similar genes in other
organisms can do so using the “Homolog Comparative Viewer” menu
available in the human TPM3 result page. Here, one can see that genes
similar to human TPM3 are present in eight different organisms
(Fig. 2H). The ‘Similarity Evidence’ ﬁeld in the Comparative Viewer
menu explains how the relationships of these genes to human TPM3
were established in AspAlt. TPM3 in Canis familiaris, Tm1 in Droso-
phila melanogaster and Tpm3 in Rattus norvegicus are assigned with
the ‘Similarity Evidence’ of ‘Known Homolog’ since these genes are
annotated in the HomoloGene database [39] as valid homologs of
human TPM3. The remaining ﬁve genes from Danio rerio,Monodelphis
domestica, Mus musculus, Macaca mulatta and Ornithorhynchus
anatinus are not annotated in HomoloGene as homologs of human
TPM3. However, one can see that all ﬁve genes share the exact
same gene symbol with human TPM3. Perhaps further analysis of
these genes might reveal whether any of them have extensive
sequence and functional similarity with human TPM3. These genes
are hence assigned with the ‘Similarity Evidence’ of ‘Potential
Homolog’ in AspAlt and users can explore the detailed annotations
of each of these potential homologs by clicking on their individual
gene symbols, each of which are interlinked to the corresponding
information pages in their source databases. Users can analyze the
annotations available in these pages and then make individualjudgments on whether they wish to consider these potential
homologs for comparative AT–AS analysis. Once the user chooses
a set of genes of interest in the comparative viewer menu and clicks
the submit button, the graphical AT–AS plots of the selected genes
are displayed in a single web page, thus allowing users to compare
and analyze the differences in AT–AS events among them in detail
(Supplementary Fig. 1).
Dynamic AT–AS classiﬁer
We realized that it is important to provide users with the ﬂexibility
to analyze AT–AS events in their own datasets independent of the pre-
calculated AT–AS data of 46 organisms available in AspAlt. The
dynamic AT–AS classiﬁer tool developed for this purpose classiﬁes
AT–AS events on-the-ﬂy in user-submitted intron–exon structure
annotations of mRNA isoforms and display graphical AT–AS plots of
this data for comparative analysis. Since the dynamic classiﬁer
submission format is compatible with the Entrez Gene database's
“Gene Table” display format, it can be used for direct analysis of AT–AS
events in any alternatively spliced gene present in the Entrez Gene
database.
Customized comparative analysis of AT–AS events
AspAlt allows researchers to submit batch queries of multiple gene
identiﬁers associated with any of the 1,58,876 genes stored in its
database, then, retrieve and analyze the variations in AT–AS proﬁles
in such user-speciﬁed gene lists. Other features in AspAlt which
allow customized AT–AS comparative analysis include the facilities to
submit keyword searches (example: retrieve all genes which have the
Table 1B
AspAlt data contents for 30 organisms which have non-overlapping mRNA annotations in E: Ensembl. R: RefSeq and A: AceView databases.
Organism (phylum; sub group) Genes with AT–AS events/total Genesa
(percentage of AT–AS genes)
Avg. no. of
mRNA isoformsa
Total no. of
AT–AS events
Avg. no. of
AT–AS eventsa
Pongo pygmaeus albelii (Chordata; mammals) E: 2767/24630 (11.23) E: 2.25 E: 11338 E: 4.1
Otolemur garnettii (Chordata; mammals) E: 5/19028 (0.03) E: 2 E: 15 E: 3
Tupaia belangeri (Chordata; mammals) E: 4/17570 (0.02) E: 2 E: 6 E: 1.5
Spermophilus tridecemlineatus (Chordata; mammals) E: 3/16378 (0.02) E: 2 E: 3 E: 1
Cavia porcellus (Chordata; mammals) E: 140/16910 (0.83) E: 2.11 E: 1170 E: 8.36
Sorex araneus (Chordata; mammals) E: 5/15792 (0.03) E: 2 E: 10 E: 2
Erinaceus europaeus (Chordata; mammals) E: 4/17607 (0.02) E: 2 E: 6 E: 1.5
Myotis lucifugus (Chordata; mammals) E: 4/18786 (0.02) E: 2 E: 6 E: 1.5
Xenopus tropicalis (Chordata; amphibian) E: 4222/18932 (22.3) E: 3.29 E: 59065 E: 13.99
Takifugu rubripes (Chordata; ﬁsh) E: 10635/19094 (55.7) E: 3.76 E: 167352 E: 15.74
Oryzias latipes (Chordata; ﬁsh) E: 3809/20198 (18.86) E: 2.31 E: 20413 E: 5.36
Gasterosteus aculeatus (Chordata; ﬁsh) E: 5290/22255 (23.77) E: 2.28 E: 29171 E: 5.51
Tetraodon nigroviridis (Chordata; ﬁsh) E: 2702/20106 (13.44) E: 2.3 E: 16690 E: 6.18
Ciona intestinali (Chordata; sea squirt) E: 3788/14462 (26.19) E: 2.5 E: 31569 E: 8.33
Ciona savignyi (Chordata; sea squirt) E: 3359/12087 (27.79) E: 3.54 E: 58515 E: 17.42
Strongylocentrotus purpuratus (Echinodermata) R: 285/42219 (0.68) R: 2.41 R: 983 R: 3.45
Aedes aegypti (Arthropoda; insect) E: 992/16691 (5.94) E: 2.38 E: 2471 E: 2.49
Drosophila pseudoobscura (Arthropoda; insect) R: 70/9769 (0.72) R: 2.44 R: 214 R: 3.06
Tribolium castaneum (Arthropoda; insect) R: 57/9605 (0.59) R: 2.11 R: 142 R: 2.49
Nasonia vitripennis (Arthropoda; insect) R: 74/9163 (0.81) R: 2.23 R: 201 R: 2.72
Apis mellifera (Arthropoda; insect) R: 100/9119 (1.1) R: 2.2 R: 288 R: 2.88
Chlamydomonas reinhardtii (Plantae; algae) R: 66/14339 (0.46) R: 2.11 R: 197 R: 2.98
Cryptococcus neoformans (fungi) R: 278/6273 (4.43) R: 2.15 R: 579 R: 2.08
Yarrowia lipolytica (fungi) R: 1/6520 (0.02) R: 2 R: 3 R: 3
Debaryomyces hansenii (fungi) R: 6/6311 (0.1) R: 2 R: 12 R: 2
Candida glabrata (fungi) R: 1/5180 (0.02) R: 2 R: 2 R: 2
Schizosaccharomyces pombe (fungi) R: 2/5033 (0.04) R: 2 R: 2 R: 1
Dictyostelium discoideum (protozoa) R: 9/13362 (0.07) R: 2 R: 12 R: 1.33
Plasmodium falciparum (protozoa) R: 4/5266 (0.08) R: 2 R: 8 R: 2
Leishmania braziliensis (protozoa) R: 1/7897 (0.01) R: 2 R: 2 R: 2
a Average value calculated out of the total number of AT–AS genes.
51A. Bhasi et al. / Genomics 94 (2009) 48–54keyword “lymphoma”) or AT–AS event-based searches (example:
retrieve all mouse genes which have intron retention events). These
searches retrieve multiple gene hits fromwhich users can select genes
of interest and compare AT–AS patterns among them. Users can also
submit customized mRNA exon–intron annotations of a large number
of genes and use the dynamic AT–AS classiﬁer to create their AT–AS
plot.
These user-friendly features in AspAlt present great ﬂexibility in
comparative analysis of AT–AS among gene datasets of interest and
would be particularly useful for comparing AT–AS patterns among
genes which share a common function, among phylogenetically
related gene groups or among genes found to be differentially
expressed in a particular disease state.
Browsing the genomic AT–AS data
AspAlt's “Browse Genomes” page provides access to the genomic
distribution of AT–AS events. Here, users can browse through each of
the 46 genomes and access AT–AS events in genes present on each
chromosome of a genome. The genes in each chromosome are
arranged in alphabetical order based on their genes symbols and
speciﬁc color-codes are assigned to indicate the inter-database
availability of AT–AS data from the three source databases.
Bulk genomic data downloads
One of the unique features of AspAlt is the availability of genomic
AT–AS data ﬁles for bulk download. This is very useful for people
interested in performing customized large-scale analysis of genome-
wide and inter-genomic AT–AS distributionswithout being dependant
on querying the AspAltweb interface. The genomic AT–AS dataﬁles for
all 46 organisms are available in XML and simple tab-delimited text
formats in AspAlt's “Downloads”web page. Each XML genomic AT–AS
data ﬁles was generated using the “XML::Writer” Perl module and issupported by a well-deﬁned Document Type Deﬁnition (DTD) with
formal descriptions of the structural elements andmarkup deﬁnitions.
TheDTDensures that the complex genomicAT–ASdata in theXMLﬁles
are presented in a highly structured format, well suited for efﬁcient
data extraction and analysis.
Future development
AspAlt currently provides a number of unique features for
comparative analysis of the distribution of AT–AS events. In future,
we plan to expand AspAlt's inter-database comparative analysis
capabilities by integrating AS annotations calculated from mRNA
annotations available in speciﬁc AS databases such as ASD andH-DBAS
into AspAlt. We also plan to enhance the genomic AT–AS coverage in
AspAlt by calculating the AT–AS patterns from mRNA annotations
available in GenBank [40], TIGR [41] and Gramene [42]. We will also
implement tools for comparative sequence analysis of homologous
AT–AS genes and for in-depth phylogenetic comparative analysis of
AT–AS events across diverse organisms.
Materials and methods
Data extraction and integration
Data was extracted from the following ﬁles downloaded on
September 15th, 2008: (1) Ensembl gene annotation (gtf format)
ﬁles of 31 organisms from ‘ftp://ftp.ensembl.org/pub/current_gtf/’;
(2) RefSeq gene annotation (seq_gene.md) ﬁles of 30 organisms from
‘ftp://ftp.ncbi.nih.gov/genomes/MapView/’ and (3) AceView mRNA
annotation (gff format) ﬁles of three organisms from ‘http://www.
ncbi.nlm.nih.gov/IEB/Research/Acembly/downloads.v67.html’; (4)
Entrez Gene's gene_info ﬁle from ‘ftp://ftp.ncbi.nlm.nih.gov/gene/
DATA’; and (6) HomoloGene's HomoloGene.data ﬁle from ‘ftp://ftp.
ncbi.nih.gov/pub/HomoloGene/current’.
Fig. 2. Results of a sample query for human TPM3 (Tropomysin 3) gene in AspAlt. (A) AspAlt's result page with the inter-database comparative viewer displaying Ensembl-based,
RefSeq-based and AceView-based plots of TPM3; (B) Inter-Db AT–AS Event Variation page; (C) link integration to the detailed annotation of a transcript isoform in one of AspAlt's
source databases; (D) Gene Details page; (E) AT–AS Event Details page; (F) XML and Tab-Delimited formats of AT–AS annotations; (G) Zoomed In View of AspAlt plots; and (H)
Homolog Comparative Viewer menu.
52 A. Bhasi et al. / Genomics 94 (2009) 48–54The extraction procedure involved the development of a pipeline
implemented in Perl programming language which ﬁrst isolated
annotation data associatedwith all geneswhichhadmultiple transcript
isoforms in Ensembl, RefSeq and AceView data ﬁles. This resultant
datasets of 1,21,525 Ensembl, 38,839 RefSeq and 53,183 AceView genes
were then parsed and annotation data including gene and transcript
isoform identiﬁers, exon–intron position co-ordinates and other
associated data were extracted from them. Additionally, gene symbol,
gene name and gene description associated with each of the multi-
isoform genes were extracted from the Entrez Gene database.A large number of genes had overlapping annotations in Ensembl,
RefSeq and AceView. These overlapping inter-databases annotations
for the same gene were integrated as follows: inter-database cross-
linking of Ensembl and RefSeq entries of the same gene were
established using the “Ensembl Gene ID–Entrez Gene ID” mapping
data extracted from the Ensembl database using its BioMart tool
‘http://www.ensembl.org/biomart/martview’. Since AceView does
not contain Entrez Gene ID data, inter-database cross-linking of
RefSeq and AceView entries of the same gene were established using
the commonly shared Entrez Gene Symbol identiﬁer available for the
53A. Bhasi et al. / Genomics 94 (2009) 48–54gene in both RefSeq and AceView databases. Unlike RefSeq, Ensembl
database does not contain Entrez Gene Symbol data. Hence, in order to
cross-link Ensembl gene entries to their respective AceView entries,
we ﬁrst mapped Entrez Gene Symbol entries extracted from the
Entrez Gene database to the “Ensembl Gene ID–Entrez Gene ID”
mapping data that was extracted from Ensembl. This allowed us to
create an “Ensembl Gene ID–Entrez Gene ID–Entrez Gene Symbol”
mapping data ﬁle. Next, each Entrez Gene Symbol in this mapping ﬁle
was checked for matching Entrez Gene Symbols in AceView, allowing
us to effectively cross-link Ensembl gene entries to their matching
AceView gene entries.
Inter-genomic cross-referencing of “Known Homologs” was
implemented using the HomoloGene Group ID (HID) which is
associated with all genes found within a homologous gene group in
HomoloGene. All genes which shared a common HIDwere assigned as
“Known Homologs” of each other in AspAlt. Inter-genomic homolog
cross-referencingof “Potential Homologs”wasestablishedby searching
for gene symbol matches among all gene entries in AspAlt. Genes that
share a common and exact same gene symbol were assigned as
“Potential Homologs” of each other.
Classiﬁcation of AT–AS events
AT–AS events in AspAlt were annotated using a Perl programwhich
utilizes an upgraded version of the rule based classiﬁcation procedure
that had been initially developed for the EuSplice project [38]. Unlike
the EuSplice version which had only classiﬁed protein-coding mRNA
isoform data submitted in RefSeq format, the upgraded version
classiﬁes AT–AS events in both protein-coding andnon-protein-coding
mRNA isoforms and accepts input data in multiple data formats
(Ensembl, RefSeq, AceView, Entrez Gene Table).
The AspAlt AT–AS classiﬁcation program was applied to classify
AT–AS events in 1,58,876 genes from 46 organisms and this data was
stored in AspAlt's back-end MySQL database. In each gene, the
classiﬁcation program ﬁrst extracted exon–intron co-ordinates (start
and end positions) from all of its mRNA isoforms and identiﬁed
common exonic regions shared across these isoforms. These common
exonic regions were then grouped into multiple non-overlapping Gene
Exon Clusters (GECs). Next, each GEC was scanned to see if an exon in
one isoform retained the complete genic region that was deﬁned as an
intron, in another isoform. If such anexonwas found, then thatexonwas
assignedwith an IntronRetentionAS event. The next stepwas to deﬁne,
a constitutive exon within each GEC. For this, only those exons which
did not have intron retention events assigned to themwere considered.
A constitutive exon was identiﬁed among such exons using the
following rules: Rule 1: the exon which is found in 50% or more of the
isoforms represented in a GECwas tagged as the constitutive exon; Rule
2: if Rule 1 fails, then the exon which had the highest frequency of
occurrence across the transcript isoforms represented in the GEC was
tagged as the constitutive exon; and (3) if Rule 2 fails, then the longest
exon within the GEC was tagged as the constitutive exon.
Once constitutive exonswere deﬁned, the remaining ﬁve AS events
were deﬁned in each GEC using the following rules: (1) Alternative
Donor: if an exon had a donor splice site different from that of the
constitutive exon, then that exon was assigned with an alternative
donor site. (2) Alternative Acceptor: if an exon had an acceptor splice
site different from that of the constitutive exon, then that exon was
assigned with an alternative acceptor site. (3) Alternative Donor and
Acceptor: if both the donor and acceptor splice sites of an exon were
different from that of the constitutive exon, then that exon was
assigned with both alternative donor and alternative acceptor sites.
(4) Skipped Exon: if an exon was present in 50% or more of the
isoforms, then the regions in each of the remaining isoforms in which
this exon was absent were each assigned with a skipped exon event.
(5) Cryptic Exon: if an exon was present in only less than 50% of the
isoforms, then it was designated as a cryptic exon.In order to assign ATI and ATT events in transcript isoforms,
Constitutive Transcription Initiation (CTI) and Constitutive Trans-
cription Termination (CTT) locations were ﬁrst deﬁned using the
following rules: (1) The Transcription Initiation (TI) location which
had the highest frequency of occurrence among the mRNA isoforms
was designated as the CTI and the Transcription Termination (TT)
location which had the highest frequency of occurrence among the
mRNA isoforms was designated as the CTT. (2) If a CTI or CTT could not
be assigned using the above mentioned rule, then the most upstream
TI was designated as the CTI and the most downstream TT was
designated as the CTT. All isoforms which had TI locations that were
different from the CTI were tagged with ATI events and those with TT
locations different from the CTT were tagged with ATT events.
Database and web interface development
AspAlt web service was developed in Perl CGI (www.cpan.org) and
runs on an Apache 2.0.53 (www.apache.org) web server. For efﬁcient
retrieval of data, the AT–AS events and associated annotations were
populated to MySQL 4.1 (www.mysql.com) database. Perl CGI scripts
which utilize the Perl DBI module were developed to efﬁciently query
and retrieve this data from the database. To keep the AT–AS data in
AspAlt up-to-date, we will perform synchronized updates to the
AspAlt database when transcript annotation updates occur in
Ensembl, RefSeq and AceView databases.
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